U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07057154) titled 'Glycated Hbg Index and RDW as Prognstic Indicator in Critical Ill Patients' on May 29.
Brief Summary: The aim of this study was to evaluate the impact of GHI and RDW as prognostic indicator in critically ill Patients.
Study Start Date: July 05
Study Type: OBSERVATIONAL
Condition:
Critical Ill Patients
Intervention:
DEVICE: Hbg and RDW
Hbg and RDW as prognstic indicator in critical ill patients
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Assiut University
Information provided by (Responsible Party): Rania Moukhter aziz aldean, Assiut University
Published by HT Digital Content Services with permission from Health Daily ...